Literature DB >> 23628105

Pregnancy outcome after elective cervical cerclage in relation to type of suture material used.

F Israfil-Bayli1, P Toozs-Hobson, C Lees, M Slack, K M K Ismail.   

Abstract

Cervical weakness is an important cause of late miscarriage and extreme preterm labour. Women have been traditionally offered a cervical cerclage procedure, though studies failed to demonstrate a therapeutic effect. None of these studies has addressed the effect of non-braided to braided suture material on cerclage outcome. Type of suture material is an important determinant of surgical outcomes. This issue is of particular relevance to cerclage because the traditionally braided suture has been associated with increased risk of infection in other surgical procedures. Indeed, infection is an important underlying cause for cerclage failure. It is for this reason that some surgeons use non-braided suture material. Therefore, we hypothesise that the unrealised benefit of cervical cerclage is at least in part due to the type of suture material used. In this article, we present the rationale behind our hypothesis and a proposed way of testing it.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23628105     DOI: 10.1016/j.mehy.2013.04.003

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  3 in total

1.  Importance of uterine cervical cerclage to maintain a successful pregnancy for patients who undergo vaginal radical trachelectomy.

Authors:  Miseon Kim; Shin-ichi Ishioka; Toshiaki Endo; Tsuyoshi Baba; Yushi Akashi; Miyuki Morishita; Hidefumi Adachi; Tsuyoshi Saito
Journal:  Int J Clin Oncol       Date:  2013-10-31       Impact factor: 3.402

Review 2.  Radical Trachelectomy for Early Stage Cervical Cancer.

Authors:  Anthony Costales; Chad Michener; Pedro F Escobar-Rodriguez
Journal:  Curr Treat Options Oncol       Date:  2018-11-19

3.  Cerclage outcome by the type of suture material (COTS): study protocol for a pilot and feasibility randomised controlled trial.

Authors:  Fidan Israfil-Bayli; Philip Toozs-Hobson; Christoph Lees; Mark Slack; Khaled Ismail
Journal:  Trials       Date:  2014-10-27       Impact factor: 2.279

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.